TuHURA BIOSCIENCES, INC./NV Interest Paid, Excluding Capitalized Interest, Operating Activities
TuHURA BIOSCIENCES, INC./NV (HURA) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $27.97 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-06-30 was $50.00.
- TuHURA BIOSCIENCES, INC./NV interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-03-31 was $27.92K.
- TuHURA BIOSCIENCES, INC./NV interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-12-31 was $42.83K.
- TuHURA BIOSCIENCES, INC./NV interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $59.36K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $27.97K 10-Q · filed 2026-08-14 | $70.81K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2026-03-31 | $27.92K 10-Q · filed 2026-05-15 | $70.75K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $42.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $59.36K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $16.53K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |